$1.87 Billion Mycoplasma Testing Market Insights, 2020-2027 - Cell Line Testing Anticipated to Exhibit the Highest CAGR
DUBLIN, March 6, 2020 /PRNewswire/ -- The "Mycoplasma Testing Market Size, Share & Trends Analysis by Product (Instruments, Kit & Reagents, Services), by Technology (PCR, ELISA, Direct Assay, Microbial Culture), by Application, by End Use, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The global mycoplasma testing market size is expected to reach a value of USD 1.87 billion by 2027, expanding at a CAGR of 14.9%.
The demand for mycoplasma testing products is anticipated to rise in near future with growing R&D investments in the field of life sciences. Huge opportunities in the life sciences segment are spurring the market growth. Rising investment in biotechnology and pharmaceutical industries with rise in healthcare spending is expected to further fuel the growth.
Government initiatives in the form of awareness campaigns for chronic diseases, such as cancer are also encouraging research-based activities. The National Research Council's Industrial Research and Assistance Program (NRC-IRAP) provides technological support to small and medium scale life science companies in Canada involved in product development and innovation. According to Saudi Arabia's 2030 Vision, its government is promoting growth of pharmaceutical industries due to the fact that only 30% of its medication requirements are produced locally. Such factors are expected to drive the market growth.
Mycoplasma contamination of cell culture is a growing concern for most of the researchers for decades. Mycoplasma infection arises majorly from laboratory workers as human mycoplasma contamination occurs at a faster rate. In order to combat further contamination, mycoplasma tests are conducted, which is expected to increase the demand for the related products and hence, the market growth.
Further key findings from the study suggest:
-- In 2019, kits and reagents dominated the market and is also expected to
showcase the highest CAGR over the forecast period, owing to its
increasing usage in mycoplasma tests
-- The Polymerase Chain Reaction (PCR) segment held the largest market
share in 2019 owing to the delivery of fast and accurate results
associated with this technology
-- Cell line testing is anticipated to exhibit the highest CAGR over the
forecast period due to the increasing risk of cell line contamination
-- In 2019, pharmaceutical and biotechnology companies accounted for the
largest mycoplasma testing market share due to rising research
activities in drug discovery and development
-- North America dominated the market in 2019 owing to rising healthcare
spending levels and government funding for life science-related research
-- Asia Pacific is expected to expand at an exponential CAGR during the
forecast period, attributed to increase in healthcare spending along
with rise in demand for better infrastructure in laboratory and clinical
research
-- Some of the key market players are Merck KGaA, Thermo Fisher Scientific,
Lonza Group Ltd., Charles River Laboratories International, Inc.,
PromoCell GmbH, and Bionique Testing Laboratories, Inc.
Key Topics Covered
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Mycoplasma Testing Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing R&D investments in life sciences
3.3.1.2 Rising government support towards pharmaceutical and biotechnology industries
3.3.1.3 Rising cell culture contamination
3.3.1.4 Growing demand for the introduction of effective treatment of life-theratening diseases
3.3.2 Market Restraint Analysis
3.3.2.1 High cost of research in cell biology
3.3.2.2 Slow rate of mycoplasma growth
3.3.2.3 Possibility of false negative results
3.3.3 Industry challenges
3.4 Mycoplasma Testing Market Analysis Tools
3.4.1 Industry analysis - Porter's
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Environmental Landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal Landscape
3.4.3 Major deals and strategic alliances analysis
3.4.3.1 Joint ventures
3.4.3.2 Mergers and acquisitions
3.4.3.3 Licensing and partnership
3.4.3.4 Technology collaborations
3.4.3.5 Strategic Divestments
3.4.4 Market entry strategies
Chapter 4 Mycoplasma Testing Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2019
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive dashboard analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis
Chapter 5 Mycoplasma Testing Market: Product Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2019 & 2027
5.3 Segment Dashboard
5.4 Global Mycoplasma Testing Market, by Product, 2016 to 2027
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
Chapter 6 Mycoplasma Testing Market: Technology Estimates And Trend Analysis
6.1 Definition & Scope
6.2 Technology Market Share Analysis, 2019 & 2027
6.3 Segment Dashboard
6.4 Global Mycoplasma Testing Market, by Technology, 2016 to 2027
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
Chapter 7 Mycoplasma Testing Market: Application Estimates And Trend Analysis
7.1 Definition & Scope
7.2 Application Market Share Analysis, 2019 & 2027
7.3 Segment Dashboard
7.4 Global Mycoplasma Testing Market, by Application, 2016 to 2027
7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
Chapter 8 Mycoplasma Testing Market: End Use Estimates And Trend Analysis
8.1 Definition & Scope
8.2 End Use Market Share Analysis, 2019 & 2027
8.3 Segment Dashboard
8.4 Global Mycoplasma Testing Market, by End Use, 2016 to 2027
8.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
Chapter 9 Mycoplasma Testing Market: Regional Estimates & Trend Analysis
9.1 Regional Market Snapshot
9.2 Regional Market Share and Leading Players, 2019
9.3 Market Share Analysis by Country, 2019
9.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.5 Market Size & Forecasts, and Trend Analysis, 2019 to 2027
Chapter 10 Company Profiles
10.1 Companies Profiled
10.1.1 Thermo Fisher Scientific Inc.
10.1.2 Merck KGaA
10.1.3 Lonza
10.1.4 PromoCell GmbH
10.1.5 American Type Culture Collection
10.1.6 Charles River Laboratories International Inc.
10.1.7 Bionique Testing Laboratories Inc.
10.1.8 Biological Industries Israel Beit Haemek Ltd.
10.1.9 InvivoGen
For more information about this report visit https://www.researchandmarkets.com/r/927bd2
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/1-87-billion-mycoplasma-testing-market-insights-2020-2027---cell-line-testing-anticipated-to-exhibit-the-highest-cagr-301018907.html
SOURCE Research and Markets
